BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 18603142)

  • 21. Pharmacotherapy and psychotherapy of pediatric depression.
    Maalouf FT; Brent DA
    Expert Opin Pharmacother; 2010 Sep; 11(13):2129-40. PubMed ID: 20707755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of antidepressants in patients with irritable bowel syndrome and comorbid depression.
    Friedrich M; Grady SE; Wall GC
    Clin Ther; 2010 Jul; 32(7):1221-33. PubMed ID: 20678672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improving depression outcome: new concepts, strategies and technologies.
    Alpert JE
    J Psychopharmacol; 2006 May; 20(3 Suppl):3-4. PubMed ID: 16644765
    [No Abstract]   [Full Text] [Related]  

  • 24. Efficacy of the sequential integration of psychotherapy and pharmacotherapy in major depressive disorder: a preliminary meta-analysis.
    Guidi J; Fava GA; Fava M; Papakostas GI
    Psychol Med; 2011 Feb; 41(2):321-31. PubMed ID: 20444307
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relative effects of CBT and pharmacotherapy in depression versus anxiety: is medication somewhat better for depression, and CBT somewhat better for anxiety?
    Roshanaei-Moghaddam B; Pauly MC; Atkins DC; Baldwin SA; Stein MB; Roy-Byrne P
    Depress Anxiety; 2011 Jul; 28(7):560-7. PubMed ID: 21608087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of psychotic depression in the elderly compared with nonpsychotic depression.
    Kok R; Heeren T; Nolen W
    J Clin Psychopharmacol; 2010 Aug; 30(4):465-7. PubMed ID: 20631567
    [No Abstract]   [Full Text] [Related]  

  • 27. Is remission of depressive symptoms in primary care a realistic goal? A meta-analysis.
    Dawson MY; Michalak EE; Waraich P; Anderson JE; Lam RW
    BMC Fam Pract; 2004 Sep; 5():19. PubMed ID: 15353006
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Can nonantidepressants help treat depression?
    Chilakamarri G; Weismantel D; Weismantel A
    J Fam Pract; 2009 Oct; 58(10):550-1. PubMed ID: 19874735
    [No Abstract]   [Full Text] [Related]  

  • 29. Risks in discontinuation trials with antidepressants.
    Baldessarini RJ
    J Clin Psychiatry; 2014 Dec; 75(12):e1443. PubMed ID: 25551243
    [No Abstract]   [Full Text] [Related]  

  • 30. Cognitive and behavior therapy in the treatment and prevention of depression.
    Hollon SD
    Depress Anxiety; 2011 Apr; 28(4):263-6. PubMed ID: 21456036
    [No Abstract]   [Full Text] [Related]  

  • 31. Sponsorship, antidepressant dose, and outcome in major depressive disorder: meta-analysis of randomized controlled trials.
    Sinyor M; Schaffer A; Smart KA; Levitt AJ; Lanctôt KL; Grysman NH
    J Clin Psychiatry; 2012 Feb; 73(2):e277-87. PubMed ID: 22401489
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Mood disorders in patients with chronic kidney disease. Diagnosis, screening and treatment of depression].
    Szeifert L; Hamvas S; Adorjáni G; Novák M
    Orv Hetil; 2009 Sep; 150(37):1723-30. PubMed ID: 19723601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Short psychodynamic supportive psychotherapy, antidepressants, and their combination in the treatment of major depression: a mega-analysis based on three randomized clinical trials.
    de Maat S; Dekker J; Schoevers R; van Aalst G; Gijsbers-van Wijk C; Hendriksen M; Kool S; Peen J; Van R; de Jonghe F
    Depress Anxiety; 2008; 25(7):565-74. PubMed ID: 17557313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exercise, pharmacotherapy, and depression.
    Ford JS
    Psychosom Med; 2008 Feb; 70(2):263; author reply 264-5. PubMed ID: 18256334
    [No Abstract]   [Full Text] [Related]  

  • 35. [Treatment-resistant depression: part I: background and rationale options, prediction of antidepressant response, psychotherapeutic treatment].
    Schmauss M; Messer T
    Fortschr Neurol Psychiatr; 2010 Jan; 78(1):45-57. PubMed ID: 19708001
    [No Abstract]   [Full Text] [Related]  

  • 36. Milnacipran treatment of a terminally ill cancer patient with major depressive disorder.
    Sato K; Higuchi H; Yoshida K; Takahashi H; Shimizu T; Watanabe J
    Hum Psychopharmacol; 2004 Aug; 19(6):431-2. PubMed ID: 15303248
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice.
    van der Lem R; van der Wee NJ; van Veen T; Zitman FG
    Psychother Psychosom; 2012; 81(4):226-34. PubMed ID: 22584117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The treatment of major depression].
    Berner MM
    Pharm Unserer Zeit; 2004; 33(4):304-10. PubMed ID: 15287691
    [No Abstract]   [Full Text] [Related]  

  • 39. Electroconvulsive therapy: how effective is it?
    Weiner RD; Falcone G
    J Am Psychiatr Nurses Assoc; 2011; 17(3):217-8. PubMed ID: 21653492
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical significance of transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant depression: synthesis of recent data.
    Demitrack MA; Thase ME
    Psychopharmacol Bull; 2009; 42(2):5-38. PubMed ID: 19629020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.